ABOUT US
WHO ARE WE
Pharmecons is an international outcomes research agency specializing in market access issues, health economics and patient-reported outcomes (PRO). We are based in the UK, with academic links around Europe, particularly the University of York, UK and the largest universities in Greece, which allow us to draw on emergent research in health economics, evidence based medicine, patient reported outcomes and market access portfolio.
We have extensive experience in building Markov and other decision-analytic models, discrete choice experiments, utility elicitation and other health technology assessment tools. We are experts in writing reports for reimbursement authorities, building value dossiers for the broader health-care community and communication plan with specific key messages, objection handlers and flashcards to help you elevate your research. We have a great network of international researchers such as health economists, outcomes researchers, clinical and regulatory specialists based in the UK, and Greece.
We have extensive experience in building Markov and other decision-analytic models, discrete choice experiments, utility elicitation and other health technology assessment tools. We are experts in writing reports for reimbursement authorities, building value dossiers for the broader health-care community and communication plan with specific key messages, objection handlers and flashcards to help you elevate your research. We have a great network of international researchers such as health economists, outcomes researchers, clinical and regulatory specialists based in the UK, and Greece.
EXPERTISE
MEET THE TEAM
Bio
Magda Chatzikou holds a PhD by University of Thessaly in health economics with an 18 year experience in the pharmaceutical industry. She is currently adjunct faculty at Open University of Greece at post graduate course of Health Care Management. She has served many roles in market access departments of the multinational industry emphasizing on pricing, reimbursement and health economics. Magda can be considered as the “linking chain” between clinical research and commercial value. She has worked in various therapeutic areas such as cancer, haematological disorders, diabetes, hypertension, COPD, autoimmune diseases and biosimilars. After 18 years in the industry, she decided to continue with her profession from a different perspective always linked with the pharmaceutical industry.
Bio
Micky Kerr is occupational psychologist from University of Sheffield. Micky is the director of Pharmecons Easy Access and in parallel is the leader of qualitative research to investigate apprenticeship programmes at Sheffield Hallam University. He is responsible for the design, conduction and management of the research across a range of sectors including healthcare, digital and engineering. He has collaborated with the National Institute for Health Research, Biomedical Research Centre, University of Nottingham by undertaking qualitative analyses of data collected concerning tinnitus constructs, and their meaning to patients and professionals. It has contributed to The Core Outcome Measures in Tinnitus (COMiT) initiative to develop standards for outcome measures in clinical trials. Micky was a research fellow at Barnsley Hospital, NHS Foundation Trust with a multi-disciplinary research team to develop, design, conduct, and manage research into the provision of assistive technologies; and telecare/health equipment.
Bio
Dimitra Latsou is a graduate of Political Science and Public Administration from the University of Athens, Greece. She completed the postgraduate program in Management and Economic Evaluation of Professional and Environmental Health, at the Medical School of the University of Athens. She holds a PhD from the University of Peloponnese in the scientific field: Economic Analysis of Social Policies. Dimitra has more than 12 years of experience in the field of social policy, patient reported outcomes, patient reported experience studies and economic analysis in health issues.
Stalo Charalambous, PhD
External Advisor for Cyprus & Malta
Bio
Stalo Charalambous, is a PhD holder from the University of Glasgow on the subject of molecular genetics. A trained scientist who cares to see the real impact of science on patients’ wellbeing, spent the last seventeen years in the pharmaceutical industry leading the teams of a multinational pharmaceutical company in Cyprus and Malta. Throughout her career, Stalo has served in many roles, from a medical advisor to a sales and marketing manager and then to a divisional unit head. Stalo is a commercially sharp and strategic planner, consistently contributing in exponential countries‘ sales growth in a highly competitive environment. Her experience spans the areas of oncology, hematology, Thalassaemia and rare diseases. After 17 years in the pharmaceutical industry, she decided to pursue her career from a different perspective, always linking science to commercial execution and success bringing meaningful impact to those in need.
Konstantinos Koufou
Health Economics Intern
Bio
Konstantinos Koufou is a Pharmacist from the University of Patras (Mpharm), currently studying Health Economics, Policy, and Management at Karolinska Instiutet in Stockholm, Sweden. He has years of hands-on experience in community pharmacy settings, ensuring optimal patient care and medication management.
BUSINESS CERTIFICATIONS
